{
    "2018-02-14": [
        [
            {
                "time": "2018-01-03",
                "original_text": "AbbVie Appears Ready to Start a New Advance at Any Time",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Advance",
                        "Ready"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Lilly's Taltz Positive in Phase III Label Expansion Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "Phase III",
                        "Positive"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "MTUM, BA, ABBV, C: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "MTUM",
                        "BA",
                        "ABBV",
                        "C"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare",
                        "industrials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Inside Pfizer’s Inflammation and Immunology Portfolio Performances in 2017",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Inflammation",
                        "Immunology",
                        "Portfolio",
                        "Performances"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Lilly's Taltz Positive in Phase III Label Expansion Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "Phase III",
                        "Positive"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "3 Top Stocks You Can Buy and Hold for the Next Decade",
                "features": {
                    "keywords": [
                        "Top Stocks",
                        "Buy",
                        "Hold",
                        "Decade"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Bristol-Myers Squibb’s Orencia and Other Brands in 4Q17",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Orencia",
                        "Brands",
                        "4Q17"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "3 Dividend Stocks for In-the-Know Investors",
                "features": {
                    "keywords": [
                        "Dividend Stocks",
                        "Investors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Is Now a Good Time to Buy AbbVie?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}